IPO Summary: Medtronic Spinoff MiniMed Group Falls on First Day Despite Deep IPO Discount
MiniMed Group (MMED US) a global medical technology company focused on diabetes management solutions, delivered a disappointing debut on the Nasdaq after pricing its IPO well below the originally marketed range. The company ultimately priced a full-size offering of 28.0 million shares at $20.00 per share, a significant $5 discount to the low end of the[…]
